there is a lot of talk of what's going on ? ... there is no update and what are they doing ? no update does not equal no action or laziness or incompetence. it's unrealistic to expect weekly updates.
as a few have said, I believe they are speaking to the regulators, working on dosing / patient numbers/ trial design. from there they know costs. from there they can work out how to fund it. once they know this they can push the Chinese etc etc etc. it's a pretty logical set of events that need to happen.
will it go well / how much Cash do we need / can they find non dilutive funding. dunno. but they are working on all this and I am sure they will update us when they can.
I have lost a fortune and I am not happy. but I also still believe in the science. I know it's all doom and gloom here, hence me rarely reading HC let alone adding my views, but imagine for a moment the following not doom and gloom scenario
1- fda likes the data and wants to help them get registered somehow
2- 2x2 confirm
3- reduced patients / timelines therefore reduced spend
4- tga approval
5 - we are not 100m short but a far smaller number
6- regional oa interest warms up as fda trial protocols approved
7 - potential to fill the gap with non dilutive / China upfront / options and hence no cap raise
8- board changes
I have no idea if any or all of the above are realistic but when I speak to Paul I am quite sure they aren't sitting around with their thumb up their backside. they know this is serious and they need to deliver. I am skeptical but I am waiting for fda feedback in a month or so and then from there reassess my thinking. until then, there is nothing to do but wait.
but cheer up folks. it ain't over yet.
my opinions
- Forums
- ASX - By Stock
- PAR
- General OA media and info
General OA media and info, page-520
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $96.19M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.0¢ | $55.31K | 200.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1072 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 3289 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1072 | 0.275 |
6 | 129000 | 0.270 |
2 | 19000 | 0.265 |
4 | 386233 | 0.260 |
2 | 54000 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 3289 | 1 |
0.290 | 27600 | 2 |
0.295 | 16000 | 1 |
0.300 | 2634 | 2 |
0.305 | 55400 | 4 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online